India, June 12 -- India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country's first indigenous HPV DNA tests which meet international standards for cervical cancer screening.

Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics' Truenat HPV-HR Plus met the validation criteria established by the International Agency for Research on Cancer (IARC), the specialised cancer research agency of the World Health Organization (WHO).

Cervical cancer remains one of the leading causes of cancer-related deaths among Indian women. The World Health Organization recommends HPV DNA testing as ...